Trials / Sponsors / Immune Cell, Inc.
Immune Cell, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia B Cell Leukemia, B Cell Lymphoma | Phase 1 | 2017-03-01 |
| Unknown | CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | 2017-03-01 |